Diva D. De León

5.8k total citations · 1 hit paper
121 papers, 3.9k citations indexed

About

Diva D. De León is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Diva D. De León has authored 121 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Endocrinology, Diabetes and Metabolism, 67 papers in Surgery and 25 papers in Genetics. Recurrent topics in Diva D. De León's work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (80 papers), Pancreatic function and diabetes (50 papers) and Diabetes Management and Research (34 papers). Diva D. De León is often cited by papers focused on Hyperglycemia and glycemic control in critically ill and hospitalized patients (80 papers), Pancreatic function and diabetes (50 papers) and Diabetes Management and Research (34 papers). Diva D. De León collaborates with scholars based in United States, United Kingdom and Australia. Diva D. De León's co-authors include Charles A. Stanley, Doris A. Stoffers, Katherine Lord, Rebecca A. Simmons, Biva M. Desai, Paul Thornton, Paul R. Gallagher, Nkecha Hughes, N. Scott Adzick and Jennifer Oliver‐Krasinski and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Diva D. De León

117 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children

2015 349 citations Paul Thornton, Charles A. Stanley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diva D. De León United States	35	2.4k	1.9k	925	888	516	121	3.9k
Shigeru Shibata Japan	30	1.4k 0.6×	734 0.4×	1.6k 1.7×	241 0.3×	656 1.3×	137	3.7k
Maria Grazia Castagna Italy	28	3.0k 1.2×	1.3k 0.7×	328 0.4×	425 0.5×	133 0.3×	104	3.6k
Guy Touati France	33	1.1k 0.4×	571 0.3×	1.4k 1.6×	420 0.5×	169 0.3×	94	3.7k
Giorgio Arnaldi Italy	41	4.5k 1.9×	2.7k 1.4×	676 0.7×	262 0.3×	198 0.4×	160	5.9k
I. M. Holdaway New Zealand	24	1.6k 0.7×	738 0.4×	843 0.9×	592 0.7×	271 0.5×	98	3.8k
Irina Bancos United States	39	5.2k 2.1×	4.2k 2.2×	490 0.5×	188 0.2×	199 0.4×	237	6.6k
Charles F. Verge Australia	31	2.2k 0.9×	1.8k 0.9×	533 0.6×	2.5k 2.8×	449 0.9×	69	3.8k
Holger S. Willenberg Germany	29	2.5k 1.0×	2.0k 1.0×	465 0.5×	219 0.2×	140 0.3×	105	3.7k
Markus Nauck Germany	29	933 0.4×	747 0.4×	932 1.0×	274 0.3×	259 0.5×	56	3.1k
Manjula K. Gupta United States	30	1.1k 0.4×	563 0.3×	512 0.6×	248 0.3×	304 0.6×	93	2.5k

Countries citing papers authored by Diva D. De León

Since Specialization

Citations

This map shows the geographic impact of Diva D. De León's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diva D. De León with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diva D. De León more than expected).

Fields of papers citing papers by Diva D. De León

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diva D. De León. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diva D. De León. The network helps show where Diva D. De León may publish in the future.

Co-authorship network of co-authors of Diva D. De León

This figure shows the co-authorship network connecting the top 25 collaborators of Diva D. De León. A scholar is included among the top collaborators of Diva D. De León based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diva D. De León. Diva D. De León is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

León, Diva D. De, et al.. (2025). Global Disparities in Congenital Hyperinsulinism Care. Endocrinology and Metabolism Clinics of North America. 54(2). 283–294. 1 indexed citations

Boodhansingh, Kara E., et al.. (2025). Congenital Hyperinsulinism and Long QT Syndrome Attributable to a Variant in KCNE1. Hormone Research in Paediatrics. 1–15.

León, Diva D. De, Indraneel Banerjee, Sebastian Kummer, et al.. (2024). Dasiglucagon in Children With Congenital Hyperinsulinism Up to 1 Year of Age: Results From a Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 110(8). e2674–e2681. 1 indexed citations

Juliana, Christine A., et al.. (2023). A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism. Journal of Biological Chemistry. 299(6). 104816–104816. 4 indexed citations

Peterson, Sean M., Christine A. Juliana, Ana González Hernández, et al.. (2023). Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism. Diabetes. 72(9). 1320–1329. 6 indexed citations

Thornton, Paul, Diva D. De León, David Zangen, et al.. (2023). Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children. The Journal of Clinical Endocrinology & Metabolism. 109(4). 1071–1079. 4 indexed citations

Li, Changhong, Christine A. Juliana, Ming Li, et al.. (2023). Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations. Diabetes. 72(12). 1809–1819. 8 indexed citations

Lord, Katherine, et al.. (2023). Insulin Immunoassay Interference Due to Human Antimouse Antibodies in a Patient With Ketotic Hypoglycemia. JCEM Case Reports. 1(2). luad029–luad029. 1 indexed citations

Nyirjesy, Sarah C., Amy J. Peleckis, Kathryn Gallagher, et al.. (2022). Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis. Diabetes. 71(10). 2153–2165. 10 indexed citations

10.

Wild, K. Taylor, Tomoki Nomakuchi, Sarah E. Sheppard, et al.. (2021). Hyperinsulinism in an individual with an EP300 variant of Rubinstein‐Taybi syndrome. American Journal of Medical Genetics Part A. 185(4). 1251–1255. 1 indexed citations

11.

Kelly, Andrea, Saba Sheikh, Darko Stefanovski, et al.. (2021). Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance. The Journal of Clinical Endocrinology & Metabolism. 106(9). 2617–2634. 26 indexed citations

12.

Lines, Matthew A., Klaus Brusgaard, Diva D. De León, et al.. (2021). PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia only. American Journal of Medical Genetics Part A. 185(10). 2959–2975. 5 indexed citations

13.

Nyirjesy, Sarah C., Saba Sheikh, Denis Hadjiliadis, et al.. (2018). β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL. Pediatric Diabetes. 19(7). 1173–1182. 43 indexed citations

14.

Kelly, Andrea, Diva D. De León, Saba Sheikh, et al.. (2018). Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy. American Journal of Respiratory and Critical Care Medicine. 199(3). 342–351. 78 indexed citations

15.

Hawkes, Colin P., N. Scott Adzick, Andrew Palladino, & Diva D. De León. (2016). Late Presentation of Fulminant Necrotizing Enterocolitis in a Child with Hyperinsulinism on Octreotide Therapy. Hormone Research in Paediatrics. 86(2). 131–136. 25 indexed citations

16.

Lord, Katherine, Jerilynn Radcliffe, Paul R. Gallagher, et al.. (2015). High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism. The Journal of Clinical Endocrinology & Metabolism. 100(11). 4133–4139. 96 indexed citations

17.

Wang, Hui, Nankang Hong, Kevin Yu, et al.. (2013). Mechanotransduction Drives Post Ischemic Revascularization Through K _ATP Channel Closure and Production of Reactive Oxygen Species. Antioxidants and Redox Signaling. 20(6). 872–886. 26 indexed citations

18.

Calabria, Andrew C., Changhong Li, Paul R. Gallagher, Charles A. Stanley, & Diva D. De León. (2012). GLP-1 Receptor Antagonist Exendin-(9-39) Elevates Fasting Blood Glucose Levels in Congenital Hyperinsulinism Owing to Inactivating Mutations in the ATP-Sensitive K+ Channel. Diabetes. 61(10). 2585–2591. 83 indexed citations

19.

Pinney, Sara E., Jennifer Oliver‐Krasinski, Linda M. Ernst, et al.. (2011). Neonatal Diabetes and Congenital Malabsorptive Diarrhea Attributable to a Novel Mutation in the Human Neurogenin-3 Gene Coding Sequence. The Journal of Clinical Endocrinology & Metabolism. 96(7). 1960–1965. 68 indexed citations

20.

León, Diva D. De, et al.. (2010). Use of Metformin to Control Clozapine-Associated Weight Gain in an Adolescent with Schizoaffective Disorder. Journal of Child and Adolescent Psychopharmacology. 20(2). 153–157. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact